New search | Conferencedetail
mail
Print view
 
 

2nd Integrin-Targeted Drug Development Summit

Evvnt Promotion / evvnt
-
31.08.2022 - 01.09.2022  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 08:30 - 16:00
 
Conference themes
Over the last 12 months, the industry has witnessed promising data and candidates entering the clinic. 7 Hills Pharma, Corbus Pharmaceuticals, Vincerx, and Morphic are paving the way to develop a safe, efficacious integrins-targeted drug to modify disease biology, which will be a game-changer for diseases such as oncology, autoimmune, and ophthalmology, with unmet medical needs.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/1173725-3?pid=4832

Speakers: Bernhard Wehrle-Haller, Professor, Geneva University, Bruce Rogers, President, Morphic Therapeutics, Darren G. Woodside, Vice President of Research, Texas Heart Institute, and more.
 

Enquiries and Registration:

https://go.evvnt.com/1173725-2?pid=4832
Ms. Erin Thomas
 
Categories
General Medicine
Languages
English
Congress fees
USD 2599.00 - USD 5696.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioEuropean Health Forum GasteinCenter of ExcellenceOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärzte der WeltÖsterreichische Akademie der ÄrzteHilfswerk AustriaCharité International Academy